SwiftPharma

SwiftPharma is at the forefront of biotechnology, specializing in CDMO services. By understanding market dynamics and customer needs, we create and commercially produce cutting-edge, animal-free proteins that make a significant impact today and in the future.

Our proprietary HyperXpress® bioplatform, which uses plants as mini-bioreactors, brings low-cost proteins to market with unmatched speed, scale, and accuracy. Combined with our unique molecular toolbox and adaptable infrastructure, we produce a wide array of proteins, reducing complexity and accelerating development.

Our mission is to enhance lives through biodesign. We believe in collaborating with forward-thinking partners to transform the frontier of synthetic biology. Together, we can achieve more and push the boundaries of what is possible.

Jeroen Hofenk
Founder & CSO
+32 485 92 46 41

Johan Van Havermaet
Co-Founder & COO
+32 474 61 36 30